Affiliation:
1. Rheumatology and Internal Disease Department, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland
2. Nephrology, Transplantology and Internal Disease Department, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland
3. National Institute of Cardiology, Warsaw, Poland
Abstract
Background:
GPA is necrotizing inflammation of the small vessels with granulomas.
Kidney involvement deteriorated its prognosis.
Objective:
Comparison of GPA patients with Kidney (KI) and without Kidney Involvement (nKI).
Material and methods:
We conducted a cross-sectional study of 50 consecutive adult GPA patients,
25 KI from Nephrology and 25 nKI from the Rheumatology Department of Central Clinical
Hospital Ministry of Interior in Warsaw. We analyzed clinical features, organ involvement, laboratory,
serological, imaging, histopathological data, BVAS and treatment.
Results:
The mean age of KI patients was statistically older than nKI (67.3±9.5 vs. 55.1±15.9,
p=0.002). Generalized, severe, disease resistance was observed respectively in 92% vs. 44%,
p<0.001. The number of red blood cells (3.47 vs. 4.41T/l, p<0.001), hemoglobin (10.0 vs. 12.9
g/dl, p<0.001) was lower in KI, higher mean serum creatinine (3.95 vs. 0.89 mg/dl, p<0.001), lower
GFR (20.1 vs. 79.3, p<0.001), higher CRP (median: 43.4 vs. 2.0 mg/l, p<0.001), BVAS
(16.6±4.4 vs. 10.1±6.2, p<0.001), c-ANCA (median: 119.0 vs. 15.2CU, p=0.017).
Nodules in 28% KI, in 4% nKI (p=0.048) in chest X-ray, infiltration in 43.5% KI, in 15% nKI
(p=0.042) in HRCT were observed. Skin granulomas were found in 61.5% nKI vs. 18.2% KI,
(p=0.047). Renal biopsy revealed in KI patients focal segmental glomerulonephritis in 11.8%, crescentic
glomerulonephritis in 17.6%, and pauci-immune crescentic glomerulonephritis in 70.6%.
Conclusions:
In patients with KI we found generalized, severe, resistant GPA, higher BVAS more
frequently than inpatients without KI. The results of laboratory parameters were worse in patients
with KI. Aggressive immunosuppressive treatment is often used in the KI group.
Publisher
Bentham Science Publishers Ltd.